FFCP PHASE2:Hg19::chr2:232325265..232325286,-
From FANTOM5_SSTAR
Jump to: navigation, search
| Short description: | p2@SNORD82 |
|---|---|
| Species: | Human (Homo sapiens) |
| DPI dataset: | Robust |
| TSS-like-by-RIKEN-classifier(Yes/No): | Yes |
| DHS support(Yes/No): | Yes |
| Description: | CAGE_peak_2_at_SNORD82_5end |
| Coexpression cluster: | C483_acute_diffuse_medulloblastoma_hepatocellular_small_mesothelioma_testicular |
| Association with transcript: | -112bp_to_NR_004398, uc010fxw.1_5end |
| EntrezGene: | SNORD82 |
| HGNC: | 10240 |
| UniProt: | NA |
| Genome view: | ZENBU |
View on UCSC genome browser
Mouse over to see Genome browser image, Click image to go to Genome browser
CAGE Expression
| Sample | p2@SNORD82 |
|---|
0.0
2.5
5.0
7.5
10.0
12.5
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
| Ontology term | p-value | n |
|---|---|---|
| cancer | 6.28e-24 | 235 |
| disease of cellular proliferation | 3.75e-23 | 239 |
| hematologic cancer | 9.08e-13 | 51 |
| immune system cancer | 9.08e-13 | 51 |
| cell type cancer | 1.81e-11 | 143 |
| leukemia | 1.31e-09 | 39 |
| carcinoma | 3.81e-09 | 106 |
| organ system cancer | 6.11e-08 | 137 |
Showing 1 to 8 of 8 entries
